Insomnia, sleeplessness and melatonin


Patients with insomnia may experience higher blood pressure, metabolic rate and cortisol levels, and an increased risk of falls and injuries, impairing the patients quality of life

Learning objectives

  • An understanding of healthy sleep architecture and the adverse effects of disrupted sleep
  • Knowledge of the risk factors for insomnia and its associations with major comorbidities
  • Insights into the risks and benefits of different pharmacological approaches to the management of insomnia
  • An understanding of the advantages of using exogenous melatonin for the treatment of insomnia.

To access this module, please register or login: